Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

Suzanne de Waha*, Georg Fuernau, Ingo Eitel, Philipp Lurz, Steffen Desch, Gerhard Schuler, Holger Thiele

*Corresponding author for this work
4 Citations (Scopus)


Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.

Original languageEnglish
JournalCurrent Cardiovascular Imaging Reports
Issue number2
Pages (from-to)98-107
Number of pages10
Publication statusPublished - 01.12.2011

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Measuring Treatment Effects in Clinical Trials Using Cardiac MRI'. Together they form a unique fingerprint.

Cite this